SCHEMBL10246085

SCHEMBL10246085

COC(=O)CN(Cc1cnc2ccccc2c1)S(=O)(=O)c1c(C)cc(OC)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.46
EPAS1 Q99814 1/20 0.46
FAAH O00519 2/20 0.43
MMP3 P08254 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.41
PTPN1 P18031 1/20 0.41
ALPL P05186 3/20 0.41
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CNR2 P34972 1/20 0.40
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10246213 0.86 HIF1A (0.47) HIF1AEPAS1FAAHMMP3TRPM8
SCHEMBL701618 0.83 HIF1A (0.44) HIF1AEPAS1FAAHMMP3TRPM8
SCHEMBL10246224 0.81 HIF1A (0.40) HIF1AEPAS1FAAHMMP3TRPM8
SCHEMBL12340030 0.74 LMNA (0.38) ALDH1A1LMNAPOLBCYP3A4CYP2C9
SCHEMBL13660781 0.71 ALDH1A1 (0.47) ALDH1A1LMNAKMT2A
SCHEMBL6239112 0.70 KDM4E (0.55) FAAHALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL10246259 0.69 ALDH1A1 (0.40) MMP3PTPN1ALDH1A1KMT2A
SCHEMBL2237548 0.69 MAPK1 (0.47) POLBCYP3A4CYP2C9CYP2C19HTT
SCHEMBL4820884 0.68 TRPM5 (0.55) FAAHALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL4091783 0.68 TAS2R14 (0.48) PTGESALDH1A1TSHRCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 HIF1A 630/4885EPAS1 786/4885FAAH 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.